ReviewDialogues in clinical neuroscience2011
Assessing the benefit: risk ratio of a drug--randomized and naturalistic evidence.
François Curtin et al.PubMed ↗Full text ↗
No numbers read from the abstract.
21 papers cite it
this paperpooled itcites it